The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitCentral venous catheter (CVC) removal for adult patients with candidaemiaCentral venous catheter (CVC) removal for patients of all ages with candidaemiaImaging fungal infections in childrenDatabase Research for Pediatric Infectious DiseasesInterleukin 17-Mediated Host Defense against Candida albicansEmerging drugs and vaccines for candidemiaCandida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsNew insights into innate immune control of systemic candidiasisCandida colonization index and subsequent infection in critically ill surgical patients: 20 years laterRisk prediction for invasive candidiasisIdentification of Candida glabrata genes involved in pH modulation and modification of the phagosomal environment in macrophagesStructure of Protein Geranylgeranyltransferase-I from the Human Pathogen Candida albicans Complexed with a Lipid SubstrateEpidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated CandidemiaCandida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurinHsp90 governs dispersion and drug resistance of fungal biofilmsDevelopment of a high-throughput Candida albicans biofilm chipMapping the Hsp90 genetic interaction network in Candida albicans reveals environmental contingency and rewired circuitryGlobal analysis of the evolution and mechanism of echinocandin resistance in Candida glabrataEpidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in ItalyActivity of crude extracts from Brazilian cerrado plants against clinically relevant Candida speciesEpidemiology of invasive candidiasis: a persistent public health problemMulticenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.Hospital epidemiology and infection control in acute-care settings.Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational studyPrevalence of fungal infections using National Health Insurance data from 2009-2013, South Korea.Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropeniaSaccharomyces cerevisiae: population divergence and resistance to oxidative stress in clinical, domesticated and wild isolatesInappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study.Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity.Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.Candida infections of the genitourinary tract.In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infectionsIncidence and predictors of invasive candidiasis associated with candidaemia in children.Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
P2860
Q21194915-563567EF-CDB7-4B63-AA11-222029C43CA0Q24195090-0D4933CA-8AD3-4C33-AABB-6CD9BE84DBCEQ26471135-343DCEE2-3496-4E9C-A02F-0BE7B20AE652Q26766376-8FB1FB9D-2E06-4C30-B411-3EDA1B164FE8Q26781065-ADADF87F-910E-4118-90BB-07219F97EB6EQ26798127-2B46EEDC-F9B0-458F-84F3-385627B4AAB4Q26828993-C117CA99-F1CE-423D-B63A-7F6A4D589FEDQ26863344-9740A4D6-1DB8-45F3-9F58-CCDA86026B6BQ27002519-39D69B89-FCE6-4E1A-86C8-4AAF2F4DDDB8Q27012454-A4083C6A-CFE8-4DA7-9045-6A0142BDB7EFQ27023082-42D1FA1B-6C7B-4294-8AC9-2AAE4F030C5BQ27335258-E4CA8C53-1A1A-404E-94DC-CAF1A54EDC0CQ27651678-FF6BD7E3-A4D4-48F0-961E-6D212F051D3EQ28109664-4D79BF1A-018E-46BB-872C-3D1BF97F967AQ28471781-289E470F-5AB7-4235-B28F-543EECCD3D24Q28475333-B3F59C83-F144-4BB7-80C4-2E2106FE8FCEQ28475818-13632F6C-B73F-4EAD-ACAF-033B39BEC3DBQ28476836-5BA12EC3-B568-4BE6-BB37-A88BD59C5C47Q28477874-C23B74E5-C460-483F-AC5A-D8E2300F8C84Q28481516-CE259435-3811-4A4D-B901-6D0517AA5AE3Q28483785-D50387CB-0703-438B-891C-A618873A572DQ28740362-7D4F0708-5952-4C4B-8934-4F2FC25E4E7BQ28830609-FA0D2981-37EC-407E-8470-E88637AB0E9BQ29616758-86AF46DA-0BE4-4472-8945-44AC4145FAECQ30300387-B061725F-275B-4E80-96CA-396F1C204E5CQ30429049-230459C5-58E5-46CA-91B7-75741BCF8EB5Q30781344-2C949CB0-1470-4BA8-874D-ECA4B75921C6Q30865768-AB305F50-F052-40E7-84A2-CE29A4328A56Q33265510-760DEF69-D454-4D75-AE46-2F2352DFB9C7Q33434488-08DDD479-4D9D-41C9-8F4B-1EC6D092B1AEQ33595137-A3047B42-8EFF-4EBA-BA1D-C983412FEBF8Q33602928-C28D23BB-CE44-4E72-95F0-86234C3C71CEQ33603993-DDD4B78F-AE11-4BA7-9CB7-8472297F5C34Q33683476-744CA7E9-F208-4720-936B-7E82B21AB490Q33816237-B61D03AB-B26B-40C4-B3C0-B2B2A4D715BCQ33825621-1C50AC17-64FD-4C2B-ADEC-E304241B77ADQ33851255-AAEB05B9-BA91-4730-9C8C-0461C57E3AA1Q33926760-CCC2765D-943D-4B3D-98BA-568BF25C15E5Q34006585-CDB5340F-4577-43E4-84D5-1EB256B9F19EQ34036214-9724C9C5-62D1-4958-A86D-0C49FD6F7184
P2860
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The epidemiology and attributa ...... States: a propensity analysis.
@en
The epidemiology and attributa ...... States: a propensity analysis.
@nl
type
label
The epidemiology and attributa ...... States: a propensity analysis.
@en
The epidemiology and attributa ...... States: a propensity analysis.
@nl
prefLabel
The epidemiology and attributa ...... States: a propensity analysis.
@en
The epidemiology and attributa ...... States: a propensity analysis.
@nl
P2093
P2860
P356
P1476
The epidemiology and attributa ...... States: a propensity analysis.
@en
P2093
Chris Feudtner
Jaclyn Chu
Jesse A Berlin
Jesse Argon
Theoklis E Zaoutis
Thomas J Walsh
P2860
P304
P356
10.1086/496922
P407
P577
2005-09-20T00:00:00Z